US2021127683A1PendingUtilityA1
Methods and compositions of insect control
Est. expiryDec 31, 2035(~9.5 yrs left)· nominal 20-yr term from priority
Y02A40/146C12N 15/81C12N 2795/16023A01N 63/60C12N 2770/00042C12N 15/113C12N 2310/14C07K 14/005C12N 15/70C12N 15/1131C12N 2795/18023A01N 63/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A virus-like-particle (VLP) for controlling target insects, the VLP comprising a bacteriophage capsid protein encapsidating an RNA transcript comprising at least one bacteriophage pac sequence coupled to an RNAi precursor sequence targeted against a gene transcript of the insect to suppress expression of the gene in the insect.
2 . The VLP of claim 1 , wherein the bacteriophage capsid protein derives from a levivirus.
3 . The VLP of claim 2 , wherein the levivirus is Qβ.
4 . The VLP of claim 2 , wherein the levivirus is MS2.
5 . The VLP of claim 1 , wherein the RNAi precursor forms an siRNA.
6 . The VLP of claim 1 , wherein the RNAi precursor forms an antisense RNA.
7 . The VLP of claim 1 , wherein the RNA transcript comprises a first bacteriophage pac site, followed by an antisense sequence of the gene, followed by an RNA sequence capable of forming a single-stranded loop, followed by a sense sequence complementary to the antisense sequence of the gene, followed by a second bacteriophage pac site.
8 . The VLP of claim 1 , wherein the RNA transcript comprises a bacteriophage pac site, followed by an antisense sequence of the gene, optionally followed by one or more bacteriophage pac sites.
9 . The VLP of claim 1 , wherein the gene is an essential gene.
10 . The VLP of claim 9 , wherein the essential gene is a gene controlling a larval development event, a gene encoding cellular structural components, or a gene encoding nucleic acid replication, transcription, or translation.
11 . The VLP of claim 9 , wherein suppression of the essential gene results in death of the insect.
12 . The VLP of claim 9 , wherein suppression of the essential gene results in the production of sterile off-spring.
13 . The VLP of claim 9 , wherein the essential gene encodes β-actin.
14 . The VLP of claim 1 , wherein the target insect is a Lepidopteran insect.
15 . The VLP of claim 1 , wherein the target insect is a Coleopteran insect.
16 . The VLP of claim 15 , wherein the Coleopteran insect is bark beetle, elm leaf beetle, Asian longhorn beetle, death watch beetle, mountain pine beetle, coconut hispine beetle, a corn rootworm, or Colorado potato beetle.
17 . The VLP of claim 1 , wherein the target insect is Colorado potato beetle.
18 . The VLP of claim 17 , wherein the gene encodes β-actin, and the RNAi precursor sequence is encoded by nucleotides 314-1219 of SEQ ID NO: 6.
19 . The VLP of claim 17 , wherein the gene encodes β-actin, and the RNAi precursor sequence is encoded by nucleotides 317-820 of SEQ ID NO: 9.
20 . A combination of two or more VLPs of claim 1 , wherein each RNAi precursor sequence is targeted against a different gene transcript of the insect to suppress expression of each targeted gene in the insect.Join the waitlist — get patent alerts
Track US2021127683A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.